“We will Appraise how the commercialization of the compound matches in with our company product at Adastra in an effort to place ourselves to support the demand from customers for a safe supply of copyright,” reported chief executive officer Michael Forbes in a very news release. The corporate informed VICE News it wouldn't be commenting more.�